Brief: Wuhan Yzy Biopharma Posts FY Loss Of RMB191.7 Mln
28/03/2024 13:47
March 28 (Reuters) - Wuhan YZY Biopharma Co Ltd
2496.HK :
* FY LOSS RMB191.7 MILLION VERSUS LOSS RMB188.9 MILLION
Further company coverage: 2496.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Wuhan YZY Biopharma
See all newsBrief: HKEX Says Trading In Wuhan Yzy Biopharma H Shares Halted
Brief: Wuhan Yzy Biopharma Co Says NDA For M701 Accepted By NMPA For Treatment Of Malignant Ascites
Brief: Wuhan Yzy Biopharma Says M701 Receives IND Approval From FDA
Brief: Wuhan YZY Biopharma Says Wuhan Yiruide To Buy Land Use Right And Building
Brief: Wuhan Yzy Biopharma Says Y225 Receives IND Approval From NMPA